Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chronic Infusional Epoprostenol for Severe Primary Pulmonary Hypertension
NCT00004754Phase 4Completed
- Sponsor
- National Center for Research Resources
- Start
- Aug 1993
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of epoprostenol in pulmonary arterial hypertension (PAH), sponsored by National Center for Research Resources. Started Aug 1993; status: completed.
02
Drugs
epoprostenol
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT00004754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004754.